Platelet-activating factor receptor

Journal of Biochemistry

Volumn 131, Issue 6, 2002, Pages 773-779

  Honda, Zen ichiro ^a   Ishii, Satoshi ^a   Shimizu, Takao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bronchial asthma; Endotoxin shock; G protein coupled receptors; Oxidized phospholipids; Platelet activating factor

Indexed keywords

PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; CELL SURFACE RECEPTOR; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN;

ALLERGY; ASTHMA; ATHEROSCLEROSIS; CELL MOTILITY; CHEMICAL STRUCTURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE EXPRESSION; GENE STRUCTURE; HUMAN; INFLAMMATION; LIPID ANALYSIS; LIPID OXIDATION; MEDIATOR; MEDIATOR RELEASE; MOLECULAR CLONING; NERVOUS SYSTEM FUNCTION; NONHUMAN; PROTEIN FAMILY; REPRODUCTION; SEPTIC SHOCK; SHORT SURVEY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; STRUCTURE ACTIVITY RELATION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; METABOLISM; PHYSIOLOGY; PROTEIN CONFORMATION; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MEMBRANE PROTEINS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN CONFORMATION; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 0036594254     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a003164     Document Type: Short Survey

References (73)

1. Leukocyte-dependent histamine release from rabbit platelets: The role of IgE, basophils and a platelet-activating factor
2. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine
3. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators)
4. Platelet activating factor: A biologically active phosphoglyceride
5. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice
6. Platelet-activating factor and related lipid mediators
7. Platelet-activating factor receptor: Gene expression and signal transduction
8. 2+-dependent translocation domain with homology to PKC and GAP
9. Role of cytosolic phospholipase A2 in allergic response and parturition
10. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2
11. Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase
12. cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolase
13. Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases
14. Purification and characterization from rat kidney membranes of a novel platelet-activating factor (PAF)-dependent transacetylase that catalyzes the hydrolysis of PAF, formation of PAF analogs, and C2-ceramide
15. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells
16. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines
17. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
18. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines
19. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position
20. Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques: Relevance to progression of atherosclerosis
21. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice
22. Platelet-activating factor acetylhydrolase prevents myocardial ischemia-reperfusion injury
23. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates
24. Adhesion and signaling in vascular cell-cell interactions
25. A new class of membrane-bound chemokine with a CX3C motif
26. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase
27. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes
28. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung
29. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes
30. A murine platelet-activating factor receptor gene: Cloning, chromosomal localization and upregulation of expression by lipopolysaccharide in peritoneal resident macrophages
31. Mapping of single amino acid residues required for selective activation of Gq/11 by the m3 muscarinic acetylcholine receptor
32. Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling
33. The third intracellular domain of the platelet-activating factor receptor is a critical determinant in receptor coupling to phosphoinositide phospholipase C-activating G proteins. Studies using intracellular domain minigenes and receptor chimeras
34. Mutation of a putative amphipathic alpha-helix in the third intracellular domain of the platelet-activating factor receptor disrupts receptor/G protein coupling and signaling
35. Mutations of two adjacent amino acids generate inactive and constitutively active forms of the human platelet-activating factor receptor
36. Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants
37. Sequence alignment of the G-protein coupled receptor superfamily
38. Three-dimensional model of the human PAF receptor
39. Identification of transmembrane domain residues determinant in the structure-function relationship of the human platelet-activating factor receptor by site-directed mutagenesis
40. The role of N-glycosylation for functional expression of the human platelet-activating factor receptor. Glycosylation is required for efficient membrane trafficking
41. Role of cytoplasmic tail phosphorylation sites of platelet-activating factor receptor in agonist-induced desensitization
42. Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells
43. Structural and functional requirements for agonist-induced internalization of the human platelet-activating factor receptor
44. Agonist-induced sequestration, recycling, and resensitization of platelet-activating factor receptor. Role of cytoplasmic tail phosphorylation in each process
45. Role of phospholipase Cb3 phosphorylation in the desensitization of cellular responses to platelet-activating factor
46. Gq pathway desensitizes chemotactic receptor-induced calcium signaling via inositol trisphosphate receptor down-regulation
47. Two different promoters direct expression of two distinct forms of mRNAs of human platelet-activating factor receptor
48. Platelet-activating factor receptor. Gene structure and tissue-specific regulation
49. Transcriptional regulation of platelet-activating factor receptor gene in B lymphoblastoid Ramos cells by TGF-b
50. Positive and negative regulations of human platelet-activating factor receptor transcript 2 (tissue-type) by estrogen and TGF-b1
51. Tissue-specific response of the human platelet-activating factor receptor gene to retinoic acid and thyroid hormone by alternative promoter usage
52. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells
53. Inverse agonist activity of selected ligands of platelet-activating factor receptor
54. o-protein alpha-subunits activate mitogen-activated protein kinase via a novel protein kinase C-dependent mechanism
55. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP
56. G-protein-coupled receptors and signaling networks: Emerging paradigms
57. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway
58. u-src monoclonal antibody inhibits activation of phospholipase C in platelets. A new mechanism for platelet-activating factor responses
59. RGS16 attenuates galphaq-dependent p38 mitogen-activated protein kinase activation by platelet-activating factor
60. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons
61. Wortmannin inhibits mitogen-activated protein kinase activation by platelet-activating factor through a mechanism independent of p85/p110-type phosphatidylinositol 3-kinase
62. Protein kinase C delta specifically associates with phosphatidylinositol 3-kinase following cytokine stimulation
63. Implication of protein kinase C alpha in PAF-stimulated phospholipase D activation in Chinese hamster ovary (CHO) cells expressing PAF receptor
64. Activation of the small GTPase rap1 in human neutrophils
65. 1-O-Alkyl-2-N-methylcarbamyl-glycerophosphocholine: A biologically potent, non-metabolizable analog of platelet-activating factor
66. Supplementation of in-vitro fertilisation culture medium with platelet activating factor
67. Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures
68. Memory enhancement by intrahippocampal, intraamygdala, or intraentorhinal infusion of platelet-activating factor measured in an inhibitory avoidance task
69. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation
70. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor
71. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor
72. Platelet-activating factor mediates acid-induced lung injury in genetically-engineered mice
73. Platelet-activating factor receptor is not required for long-term potentiation in the hippocampal CA1 region